| ||
| ||
| Prolonging first-line chemotherapy improves outcomes for patients with ... Eureka! Science News Contrary to what many oncologists believe, patients with metastatic breast cancer live longer on average if their chemotherapy is continued after their ... See all stories on this topic » | ||
| Iniparib extends overall survival in metastatic triple-negative breast cancer Eureka! Science News "These data are promising and suggest that iniparib may provide a potential new treatment option for patients with metastatic triple-negative breast cancer, ... See all stories on this topic » | ||
| ESMO: Drug Gets Good Response in Triple-Negative Breast CA MedPage Today Note that while the primary outcome was not statistically significant, this type of breast cancer carries a poor prognosis, and progression-free survival ... See all stories on this topic » | ||
| Bevacizumab Confirmed Beneficial For First-Line Ovarian Cancer Treatment Internal Medicine News Digital Network ... bevacizumab at a dose of 7.5 mg/kg (the dose used in metastatic colorectal cancer), GOG-218 used 15 mg/kg (the dose used in advanced breast cancer). ... See all stories on this topic » | ||
| 26th Year Breast Cancer Awareness Month, How Far Are We? allvoices Studies are underway to see which one works better for the treatment of early breast cancer. Researchers are also examining using a vaccine in targeting ... See all stories on this topic » | ||
| New Cancer Research Institute in Greenville News Channel 7 ... sites chosen to participate in the first clinical trial of Oncolix's Prolanta, which is being tested as a treatment for metastatic breast cancer. ... See all stories on this topic » | ||
| Sanofi-aventis, BiPar Sciences reveal BSI-201 Phase II results Pharmaceutical Business Review ... adverse events," Shaughnessy said. continues to demonstrate potential as a new treatment option for women with metastatic triple negative breast cancer. ... See all stories on this topic » | ||
| Male Hypogonadism in Patients With Advanced Cancer Medscape Dr. Vigano: There is a lack of trials of androgen replacement therapy in cancer patients, but theoretically, except for male breast cancer and metastatic ... See all stories on this topic » | ||
| Provectus Pharmaceuticals to Present at Inaugural Cancer Immunotherapy ... Kansas City Star Its oncology focus is on melanoma, breast cancer and metastatic cancers of the liver. The Company has received orphan drug designation from the FDA for its ... See all stories on this topic » | ||
| Cancer-gene testing ramps up Nature.com The tests, which will look for several dozen mutations in about a dozen genes linked to cancer, will be carried out on people with lung, breast, colorectal, ... See all stories on this topic » | ||
| TAP deal with Novartis brings ImmunoGen US$45 million upfront Pharma Times ... for the first-line treatment of HER2-positive metastatic breast cancer at the 35th European Society for Medical Oncology (ESMO) meeting in Milan, Italy. ... See all stories on this topic » | ||
| Better Drug Delivery Eradicates Tumors; Study Shows Promise for Treatment of ... Newswise (press release) "In fact, we are currently testing chitosan/IL-12 immunotherapy in metastatic breast and prostate tumor models. We feel that this is a broadly applicable ... See all stories on this topic » | ||
| Phoenix Brain Tumor Walk will be Oct. 23 in Tempe Sierra Vista Herald Brain tumor patients, including those with certain "benign" tumors, have poorer survival rates than breast cancer patients. Because brain tumors are located ... See all stories on this topic » | ||
| Letter: Looking for independent candidate 2TheAdvocate I am therefore very grateful for the Medicare services that I now receive for metastatic breast cancer and for the national health-care bill which provides ... See all stories on this topic » | ||
| AACR To Honor Leading Researchers At Breast Cancer Symposium Medical News Today (press release) ... improved care for breast cancer patients. His research breaks new ground toward a better understanding of the metastatic process and patient treatment. ... See all stories on this topic » | ||
|
| ||
| Free Online Guides: Targeted therapy promising for HER2-positive ... By Cristi Principal investigator Edith Perez, MD, Mayo Clinic in Florida, presented the results of the first ever randomized trial of trastuzumab-DM1 (T-DM1) as a first-line treatment for metastatic breast cancer. ... Free Online Guides - http://free-online-guides.blogspot.com/ | ||
| Prolonging first-line chemotherapy improves outcomes for patients ... By administrator The new results, presented at the 35th Congress of the European Society for Medical Oncology (ESMO), address an important area of debate in cancer treatment. "In metastatic breast cancer there is substantial controversy over how long ... Science News - http://www.molecularstation.com/science-news/ | ||
| Breast Cancer Mortality Rate 2008 | Free Articles About Breast ... By max Metastatic cancer or Stage 4 is diagnosed when cells from the original breast tumor have spread to other parts of your body. It is estimated that nearly 155000 women in the U.S. are currently living with metastatic breast cancer This will cause symptoms that depend on the location of ... lung" title="http://www.curedisease.info/2009/07/lung-cancer/\">lung" class="autohyperlink">www.curedisease.info/2009/07/lung-cancer/">lung cancer treatment breakthroughs Click here ... Free Articles About Breast Cancer,... - http://your-safe-mall.com/ | ||
| Breast Cancer Metastasis Sites | Health news for americans By Author In most people affected by cancer, these genetic changes happen after birth later in life. Breast Cancer Metastasis SitesIn Hereditary Cancer, ... Genetic testing can help a breast cancer patient make decisions about types of treatment and follow-care. A woman with the one of the BRCA mutations may decide to have both breasts removed completely to help reduce the risk of reoccurrence. Having your healthy breasts or ovaries removed to prevent cancer is called a ... Health news for americans - http://healthnew.us/ | ||
| More Cancer Treatment Failure | hot news and trends By admin Spiegal D., et al, "Effect of psychosocial treatment on survival of patients with metastatic breast cancer," Lancet 989: 888-889. F? R further information or f? R more information? About you and Dr. Wysong Wysong Corporation is ... hot news and trends - http://www.quicktsearch.com/ | ||
| Share The Little Things | Health News By admin Share The Little Things is a web site community for individuals living with metastatic breast cancer, their families, care givers, and loved ones. It is a. ... To learn about other diet and lifestyle choices to reduce your breast cancer risk, read my FREE book FIGHT NOW: EAT & LIVE PROACTIVELY AGAINST BREAST CANCER. Please recommend to anyone interested in breast cancer, breast cancer treatment, and breast cancer symptoms. Breast Cancer: Fight Now by Dr. Aaron Tabor ... Health News Gate - http://www.madhealth.net/ | ||
| Achilles' heel in aggressive breast tumors uncovered | Latest ... By admin A number of studies have shown that increased Nedd9 expression is associated with metastasis in a variety of human cancers, including breast cancer. Last year, Golemis's group reported that deleting Nedd9 from a mouse model of breast cancer delayed tumor growth, ... ScienceDaily (Oct. 12, 2010) — Children and young people who are diagnosed with bone cancer could benefit from better treatment in the future, thanks to new research at The University of Nottingham. ... Latest Health & Drugs News - http://news.drugs-expert.com/ | ||
| How Are Stages Of Breast Cancer Identified | Health For Americans By Author Benign tumors are growths that can't spread by intrusion or metastasis; hence, they barely develop in the area. Malignant tumors are growths that are capable of scattering by invasion and metastasis. Benign breast diseases such as mastitis ... Women with Stage 3 breast cancer possess a 54 to 67 % chance of survival. Women older than 70 years are underrepresented in breast cancer adjuvant radiation treatment trials caused by concerns about toxicity, safety and tolerance of ... Health For Americans - http://healthus.org/ | ||
| breast cancer iron on transfers – An Introduction to CoQ10 ... Perhaps as a result, a few cases have been reported in which women with metastatic breast cancer (cancer that had spread to other tissues) had a regression of their cancer after treatment with a very large amount of CoQ10 (390 mg per ... concerningdivorce.com - http://www.concerningdivorce.com/ | ||
| ESMO: Drug Gets Good Response in Triple-Negative Breast CA ... By Gillan MILAN -- Almost twice as many women with hard-to-treat triple-negative breast cancer achieved an objective response with a combination of cetuximab. ... In the study, women with good performance status and with a life expectancy of at least six months were enrolled into the trial if they were diagnosed with estrogen receptor-negative, progesterone receptor-negative, and HER2 expression-negative stage 4 metastatic breast cancer. These "triple-negative" tumors are ... emedist.com - http://emedist.com/ | ||
| A Plea to the FDA : North Denver Tribune By admin In January 2009, my mom had her last chemotherapy treatment. Since then, she's only been on Avastin. Twenty months later, she remains cancer free. Today, you'd never know that my mom has incurable breast cancer. Just a few weeks ago, she helped my ... This past summer, a panel of thirteen experts — only two of whom were breast cancer oncologists — advised the FDA to withdraw its approval of Avastin for metastatic breast cancer. While the panel admitted that Avastin does ... North Denver Tribune - http://www.northdenvertribune.com/ | ||
| Results of a Randomized Phase II Study with Erbitux in Breast ... By admin ... Germany, today announced the first results from the BALI-1 study of Erbitux® (cetuximab) in the treatment of metastatic triple-negative breast cancer (TNBC), an aggressive cancer in which early relapse and metastasis are common. ... Get Pills Today - http://www.getpillstoday.com/ | ||
| AACR to Honor Leading Researchers at Breast Cancer Symposium ... By AACR Communications Staff His research breaks new ground toward a better understanding of the metastatic process and patient treatment. Pantel will deliver his award lecture entitled, "Cancer Micrometastasis and Circulating Tumor Cells," on Thursday, Dec. ... AACR News - http://aacrnews.wordpress.com/ | ||
| Adding cetuximab to chemotherapy doubles response rate in hard-to ... By admin Their study included 173 women with metastatic cancer who were randomized to receive either cetuximab (400 mg/m3 initial dose and then 250 mg/m3 weekly) plus u p to six 3-weekly cycles of cisplatin, or cisplatin alone. Patients also had the ... h the disease, suggesting that this form of breast cancer might be further re-segmented according to molecular subtypes." Editor's Note: This article is not intended to provide medical adv ice, diagnosis or treatment. ... Cancer Health - http://www.cancer-health.info/ | ||
| Strong cancer drug results presented by Roche, Sanofi-Aventis ... T) revealed an additional analysis of the data from the Phase III EMBRACE study for eribulin mesylate, showing that this drug maintained an overall survival benefit compared with Physician's treatment choice in metastatic breast cancer ... thepharmaletter.com - http://www.thepharmaletter.com/ | ||
| Adding cetuximab to chemotherapy doubles response rate in hard-to ... By News European researchers have proven for the first time that targeting the epidermal growth factor receptor can provide substantial clinical benefit for women with hard-to-treat triple-negative breast cancer. ... "In addition to open new avenues in the field of cancer treatment, these results also have implications in the field of cancer biology". Dr André said. "They suggest that EGFR could play a role in the progression of triple-negative breast cancer." ... Science Codex - Science news,... - http://www.sciencecodex.com/ | ||
| Fox Chase researchers uncover Achilles' heel in aggressive breast ... By jeny A number of studies have shown that increased Nedd9 expression is associated with metastasis in a variety of human cancers, including breast cancer. Last year, Golemis's group reported that deleting Nedd9 from a mouse model of breast ... that has been a major drug development target, lead author on the study, Mahendra K. Singh, Ph.D., tested whether the Src inhibitor dasatinib, already approved for cancer treatment, would control the aggressive Nedd9-deficient tumors. ... Healthy For Life - http://healthyforlifes.com/ | ||
| The EDGE: PhysOrg Newsletter Tuesday, Oct 12 By Joash Mabs Contrary to what many oncologists believe, patients with metastatic breast cancer live longer on average if their chemotherapy is continued after their cancer is brought under control, a new meta-analysis shows. ... Adding the targeted drug cetuximab to a three-drug chemotherapy regimen for first-line treatment of metastatic colorectal cancer does not improve response rate, progression-free survival or overall survival, researchers reported at the 35th Congress of the ... The EDGE - http://mabsj2.blogspot.com/ | ||
| Adding Cetuximab to Chemotherapy Doubles Response Rate in Hard-to ... Adding Cetuximab to Chemotherapy Doubles Response Rate in Hard-to-Treat Breast Cancer European researchers have proven for the first time that targeting the epi. ... "In addition to open new avenues in the field of cancer treatment, these results also have implications in the field of cancer biology". Dr André said. "They suggest that EGFR could play a role in the progression of triple-negative breast cancer." Prof Baselga noted that triple-negative breast cancer probably ... Drugs.com - Clinical Trials - http://www.drugs.com/clinical_trials.html | ||
| Onco'Zine - The International Cancer Blog: Original Research ... By Standplaats: Amerika/Dr. Peter Hofland, PhD "These findings will change daily practice in the treatment of prostate cancer, in particular because they offer a novel and well-tolerated hormone therapy to patients for which no other treatment options were available. ... Principal investigator, Dr Edith Perez said the compound had shown to be effective in patients whose metastatic breast cancer had not responded to other treatments. Prof Kerr said that what has become clear "is that we need to get back to our ... Onco'Zine - The International... - http://oncozine.blogspot.com/ | ||
| Hot Stocks at NASDAQ Healthcare Sector (GNBT, ARNA, IMGN, SNSS ... By zeeshan Its products include Trastuzumab-DM1, a Phase II clinical trial product for the treatment of metastatic breast cancer; IMGN901, a Phase I clinical trial product to treat hematological malignancies, including multiple myeloma, ... Penny Stock Live - http://www.pennystocklive.com/ | ||
| The "Pink" has descended – buyer beware! « Ashley: Warrior Mom By ashleyowarriormom My journey as a woman and mother of young children who is dealing with metastatic inflammatory breast cancer. Feeds: Posts · Comments ... There are other groups out there that I will happily tell you about if you want to support either research or patients, breast cancer specific or just cancer in general. American Cancer Society, Cancer Family Care, Hospice of Cincinnati, Friends of Mel, Pink Ribbon Girls (local group), and more. Pink Ribbon Girls, Komen Cincinnati, ... Ashley: Warrior Mom - http://ashleyowarriormom.wordpress.com/ | ||
| Abc Oncology Rapidshare Free Full Downloads with Hotfile and ... Part of the American Cancer Society s acclaimed Atlas of Clinical Oncology series, this volume offers an expert overview of breast cancer. Topics range from epidemiology and genetics to diagnosis, management and reconstruction. ... A further major section addresses 3D treatment planning for conformal radiotherapy, with consideration of both external radiotherapy and brachytherapy. Subsequently the modern techniques of 3D conformal radiotherapy are described, ... Free Full Downloads with Hotfile... - http://worldsdown.net/ | ||
| Racial disparities decide quality of breast cancer care? | Health ... By staff A team of experts suggests that insurance, social and economic status is not involved with disparities in breast cancer. The study findings call for need of a better understanding about disparities in breast cancer care and accurate ... Health Jockey - http://www.healthjockey.com/2008/05/25/reiki-a-universal-healing-force/ | ||
| SciAnswers Social Media Website | Blog | Bevacizumab Confirmed ... By scianswers The first trial to show a possible benefit of bevacizumab in first-line ovarian cancer treatment was the Gynecologic Oncology Group (GOG)-218 trial (J. Clin. Oncol. 2010 [June 20 suppl.] abstract LBA1), said Dr. Tim J. Perren, a consultant medical oncologist at the St. James's Institute of ... However, whereas ICON-7 used bevacizumab at a dose of 7.5 mg/kg (the dose used in metastatic colorectal cancer), GOG-218 used 15 mg/kg (the dose used in advanced breast cancer). ... SciAnswers Social Media Website - http://socialmedia.scianswers.com/ |
| ||
| Prolonging first-line chemotherapy improves outcomes for patients ... "In metastatic breast cancer there is substantial controversy over how long ... targeted therapies effective as first-line treatment for lung cancer ... www.sciencecodex.com/prolonging_firstline_chemotherapy_i... | ||
| Breast Cancer Topic: Metastatic Breast Cancer Network's 2010 ... Breastcancer.org Home · Symptoms & Diagnosis · Treatment & Side Effects ... Metastatic Breast Cancer Network's 2010 National Conference set for October 16 ... community.breastcancer.org/forum/73/topic/759266 | ||
| PhysOrg Mobile: Prolonging first-line chemotherapy improves ... "In metastatic breast cancer there is substantial controversy over how long ... to be based on their response to treatment, how well their symptoms improve, ... pda.physorg.com/.../2010-10-prolonging-first-line-chemother... | ||
| Sloan-Kettering - Combined CT and PET Imaging May Improve ... When breast cancer spreads from its primary location to other parts of the body, ... we are concerned about metastatic breast cancer to bone," noted Maxine S. Jochelson, ... Physician Referral Service Offers Easy Access to Treatment ... www.mskcc.org/mskcc/html/100530.cfm | ||
| Community Updates in Oncology 2010: A Focus on Metastatic Breast ... Recent Updates on the Treatment of HER2-Positive. Metastatic Breast Cancer. New Insights Into the Treatment of HER2-Negative. Metastatic Breast Cancer ... www.cancerlearning.com/index.cfm/fuseaction/...id/626 | ||
| HER2 metastatic breast cancer clinical trial ... treatment (letrozole) with the HER2 inhibitor lapatinib significantly improved the outcome for patients with metastatic breast cancer that co- expressed ... www.royalmarsden.nhs.uk/research/highlights/her2 | ||
| Prolonging first-line chemotherapy improves outcomes for patients ... "In metastatic breast cancer there is substantial controversy over how long chemotherapy ... address an important area of debate in cancer treatment. ... 1click.indiatimes.com/article/0dCfey64qzdsx |
This once a day Google Alert is brought to you by Google.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment